CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+5.68%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.74B
Cap. Flow
% of AUM
99.08%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$84.5M |
| 2 |
Gilead Sciences
GILD
|
$83.7M |
| 3 |
Apple
AAPL
|
$79.3M |
| 4 |
Qualcomm
QCOM
|
$74.7M |
| 5 |
Amgen
AMGN
|
$73M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.71% |
| 4 | Industrials | 8% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $84.5M | 1.77% | +755,548 | New | +$84.5M |
|
|
2
Gilead Sciences
GILD
$140B
| $83.7M | 1.75% | +888,125 | New | +$83.7M |
|
|
3
Apple
AAPL
$3.45T
| $79.3M | 1.66% | +718,743 | New | +$79.3M |
|
|
4
Qualcomm
QCOM
$173B
| $74.7M | 1.56% | +1,004,790 | New | +$74.7M |
|
|
5
Amgen
AMGN
$155B
| $73M | 1.53% | +458,128 | New | +$73M |
|
6
Exxon Mobil
XOM
$487B
| $65M | 1.36% | +703,187 | New | +$65M |
|
7
Biogen
BIIB
$19.4B
| $63.8M | 1.33% | +188,028 | New | +$63.8M |
|
8
Johnson & Johnson
JNJ
$427B
| $56.7M | 1.19% | +542,266 | New | +$56.7M |
|
9
Pfizer
PFE
$141B
| $51M | 1.07% | +1,638,482 | New | +$51M |
|
10
Intuit
INTU
$186B
| $50.9M | 1.06% | +552,051 | New | +$50.9M |
|
11
Visa
V
$683B
| $49.5M | 1.03% | +188,763 | New | +$49.5M |
|
12
Alphabet (Google) Class C
GOOG
$2.58T
| $48.2M | 1.01% | +91,125 | New | +$48.2M |
|
13
Merck
MRK
$210B
| $47.1M | 0.98% | +828,682 | New | +$47.1M |
|
14
Parker-Hannifin
PH
$96.2B
| $45.3M | 0.95% | +351,178 | New | +$45.3M |
|
15
Microsoft
MSFT
$3.77T
| $41.6M | 0.87% | +896,160 | New | +$41.6M |
|
16
Verizon
VZ
$186B
| $41.1M | 0.86% | +878,709 | New | +$41.1M |
|
17
Berkshire Hathaway Class B
BRK.B
$1.09T
| $39.9M | 0.83% | +265,952 | New | +$39.9M |
|
18
American Express
AXP
$231B
| $39.8M | 0.83% | +428,280 | New | +$39.8M |
|
19
Coca-Cola
KO
$297B
| $39.8M | 0.83% | +943,774 | New | +$39.8M |
|
20
AbbVie
ABBV
$372B
| $36.8M | 0.77% | +562,971 | New | +$36.8M |
|
21
Cigna
CI
$80.3B
| $36.8M | 0.77% | +357,735 | New | +$36.8M |
|
22
AT&T
T
$209B
| $36.7M | 0.77% | +1,091,251 | New | +$36.7M |
|
23
Meta Platforms (Facebook)
META
$1.86T
| $36.2M | 0.76% | +463,640 | New | +$36.2M |
|
24
iShares MSCI Japan ETF
EWJ
$15.3B
| $36.1M | 0.76% | +3,215,134 | New | +$36.1M |
|
25
Colgate-Palmolive
CL
$67.9B
| $36.1M | 0.75% | +521,760 | New | +$36.1M |
|